Patients from general practice with non-specific cancer symptoms: a retrospective study of symptoms and imaging

被引:1
作者
de Chiffre, Jonas Michele Dorph [1 ,2 ]
Ormstrup, Tina Elisabeth [2 ]
Kusk, Martin Weber [2 ,3 ,4 ]
Hess, Soren [2 ,3 ,5 ,6 ]
机构
[1] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark
[2] Univ Hosp Southern Denmark, Dept Radiol & Nucl Med, Esbjerg, Denmark
[3] Univ Hosp Southern Denmark, IRIS Imaging Res Initiat Southwest, Esbjerg, Denmark
[4] Univ Coll Dublin, Sch Med, Radiog & Diagnost Imaging, Dublin, Ireland
[5] Univ Southern Denmark, Fac Hlth Sci, Dept Reg Hlth Res, Odense, Denmark
[6] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark
关键词
non-specific cancer symptoms; imaging; general practice; Denmark; retrospective studies; PREVALENCE; SURVIVAL; DENMARK; PROGRAM; PATHWAY; SWEDEN;
D O I
10.3399/BJGPO.2023.0058
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Patients with non- specific symptoms or signs of cancer (NSSC) present a challenge as they are a heterogeneous population who are not candidates for fast- track work- up in an organ- specific cancer pre- planned pathway (CPP). Denmark has a cancer pre- planned pathway for this population (NSSC- CPP), but several issues remain unclarified, for example, distribution and significance of symptoms and findings, and choice of imaging. Aim: To investigate symptoms, cancer diagnoses, and diagnostic yield of computed tomography (CT) and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDGPET/CT) in patients on NSSC- CPP to improve the overall diagnostic process. Design & settinfg: A retrospective medical chart review in a 1- year consecutive cohort (2020). Method: A total of 802 referrals were reviewed for diagnostic imaging in patients with NSSP from general practices, specialist practices, or the local hospital diagnostic centre responsible for NSSC Results: The study included 248 patients; 21% had cancer, most frequently gastrointestinal cancer (27%). The most frequent symptom was weight loss (56%). CT had a sensitivity of 85%, specificity of 87%, positive predictive value (PPV) of 65%, and negative predictive value (NPV) of 96%. For 18FFDG- PET/CT, the numbers were sensitivity 82%, specificity 62%, PPV 33%, and NPV 94%. Patients frequently underwent subsequent examinations following initial imaging. Conclusion: The findings were in accordance with the literature. Patients with NSSC had a cancer obvious focus point for future studies to further optimise the NSSC- CPP work- up strategy.
引用
收藏
页数:11
相关论文
共 45 条
  • [1] The Danish Pathology Register
    Bjerregaard, Beth
    Larsen, Ole B.
    [J]. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 : 72 - 74
  • [2] Early diagnosis of cancer: systems approach to support clinicians in primary care
    Black, Georgia B.
    Lyratzopoulos, Georgios
    Vincent, Charles A.
    Fulop, Naomi J.
    Nicholson, Brian D.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 380
  • [3] Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19
    Bosch, Xavier
    Torres, Manuel
    Moreno, Pedro
    Lopez-Soto, Alfonso
    [J]. DIAGNOSTICS, 2021, 11 (11)
  • [4] Clinical value of 18F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer
    Caspersen, Kamilla Bredlund
    Giannoutsou, Nikoletta
    Gerke, Oke
    Alavi, Abass
    Hoilund-Carlsen, Poul Flemming
    Hess, Soren
    [J]. ANNALS OF NUCLEAR MEDICINE, 2019, 33 (03) : 184 - 192
  • [5] First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer
    Chapman, D.
    Poirier, V.
    Vulkan, D.
    Fitzgerald, K.
    Rubin, G.
    Hamilton, W.
    Duffy, S. W.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 123 (5) : 722 - 729
  • [6] Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
    Coleman, M. P.
    Forman, D.
    Bryant, H.
    Butler, J.
    Rachet, B.
    Maringe, C.
    Nur, U.
    Tracey, E.
    Coory, M.
    Hatcher, J.
    McGahan, C. E.
    Turner, D.
    Marrett, L.
    Gjerstorff, M. L.
    Johannesen, T. B.
    Adolfsson, J.
    Lambe, M.
    Lawrence, G.
    Meechan, D.
    Morris, E. J.
    Middleton, R.
    Steward, J.
    Richards, M. A.
    [J]. LANCET, 2011, 377 (9760) : 127 - 138
  • [7] Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor?
    Damhus, Christina Sadolin
    Siersma, Volkert
    Birkmose, Anna Rubach
    Dalton, Susanne Oksbjerg
    Brodersen, John
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [8] Non-specific symptoms and signs of cancer: different organisations of a cancer patient pathway in Denmark
    Damhus, Christina Sadolin
    Siersma, Volkert
    Dalton, Susanne Oksbjerg
    Brodersen, John
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2021, 39 (01) : 23 - 30
  • [9] The effectiveness of the Guy's Rapid Diagnostic Clinic (RDC) in detecting cancer and serious conditions in vague symptom patients
    Dolly, Saoirse Olivia
    Jones, Geraint
    Allchorne, Paula
    Wheeler, Daniel
    Ali, Sunnyath
    Mukadam, Yaseen
    Zheng, Sifan
    Rahman, Loay
    Sindhar, Jan
    Moss, Charlotte Louise
    Harari, Danielle
    Van Hemelrijck, Mieke
    Cunliffe, Anthony
    De Michele, Luigi Vincenzo
    [J]. BRITISH JOURNAL OF CANCER, 2021, 124 (06) : 1079 - 1087
  • [10] Definition and classification of cancer cachexia: an international consensus
    Fearon, Kenneth
    Strasser, Florian
    Anker, Stefan D.
    Bosaeus, Ingvar
    Bruera, Eduardo
    Fainsinger, Robin L.
    Jatoi, Aminah
    Loprinzi, Charles
    MacDonald, Neil
    Mantovani, Giovanni
    Davis, Mellar
    Muscaritoli, Maurizio
    Ottery, Faith
    Radbruch, Lukas
    Ravasco, Paula
    Walsh, Declan
    Wilcock, Andrew
    Kaasa, Stein
    Baracos, Vickie E.
    [J]. LANCET ONCOLOGY, 2011, 12 (05) : 489 - 495